Microbial-host isozyme: A novel target in "drug the bug" strategies for diabetes.
Level V
Where this comes from
- Record sourced from PubMed, PMID 37793343.
- Also identified by DOI 10.1016/j.cmet.2023.09.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of the gut microbiome in metabolic diseases, such as diabetes, has emerged as a pivotal area of medical research. Wang et al.'s recent work reported that a gut bacteria-derived microbial-host isozyme, mimicking a human enzyme responsible for blood glucose regulation, can significantly impact the efficacy of diabetes medications.
Medical subject headings
- Diabetes Mellitus
- Gastrointestinal Microbiome
- Metabolic Diseases